Research
Energy balance
Tirzepatide administration for 72 weeks elicited significant weight reduction ranging from 5% to 20.9% across different trials in a dose-dependent manner.
Tirzepatide may be an effective option for weight management in patients with obesity and T2DM.
StrongSupportsmedium confidence
Tirzepatide administration for 72 weeks elicited significant weight reduction ranging from 5 % to 20.9 % across different trials in a dose-dependent manner.
Why this rating
The claim is based on data from multiple clinical trials.
Source
The promise of tirzepatide: A narrative review of metabolic benefits
Sara Sokary et al. · Primary care diabetes · 2025
reviewCited 24×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →